0001209191-17-002284.txt : 20170105
0001209191-17-002284.hdr.sgml : 20170105
20170105175458
ACCESSION NUMBER: 0001209191-17-002284
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170105
DATE AS OF CHANGE: 20170105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halstead Michael
CENTRAL INDEX KEY: 0001521548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 17512143
MAIL ADDRESS:
STREET 1: C/O WARNER CHILCOTT CORPORATION
STREET 2: 100 ENTERPRISE DRIVE
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-03
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001521548
Halstead Michael
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
0
1
0
0
SVP and General Counsel
Common Stock
2017-01-04
4
M
0
3107
A
23107
D
Stock Option (right to buy)
15.73
2017-01-03
4
A
0
63717
0.00
A
2027-01-03
Common Stock
63717
63717
D
Restricted Stock Units
2017-01-03
4
A
0
15893
0.00
A
Common Stock
15893
15893
D
Restricted Stock Units
2017-01-04
4
M
0
3107
0.00
D
Common Stock
3107
6216
D
Restricted stock units convert into common stock on a one-for-one basis.
On January 3, 2017, the reporting person was granted options to purchase 63,717 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Each restricted stock unit represents a contingent right to receive one share of common stock.
On January 3, 2017, the reporting person was granted 15,893 restricted stock units, vesting in three equal annual installments beginning on the
first anniversary of the grant date.
On January 4, 2016, the reporting person was granted 9,323 restricted stock units, vesting in three equal annual installments beginning on the
first anniversary of the grant date.
/s/ Lawrence J. Hineline, Attorney-in-fact
2017-01-05